Cefumax Indications/Uses

Tablet: Treatment of patients with mild to moderate infections caused by susceptible strains by the designated microorganisms: Pharyngitis/tonsillitis caused by Streptococcus pyogenes; acute bacterial otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), Moraxella catarrhalis (including β-lactamase-producing strains) or S. pyogenes; acute bacterial maxillary sinusitis caused by S. pneumoniae, or H. influenzae (non-β-lactamase-producing strains only); acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis caused by S. pneumoniae, H. influenzae (β-lactamase negative strains), or H. parainfluenzae (β-lactamase negative strains); uncomplicated skin and skin-structure infections caused by Staphylococcus aureus (including β-lactamase-producing strains) or S. pyogenes; uncomplicated urinary tract infections caused by Escherichia coli or Klebsiella pneumoniae; uncomplicated gonorrhea, urethral and endocervical, caused by penicillinase-producing and non-penicillinase-producing strains of Neisseria gonorrhoeae, and uncomplicated gonorrhea, rectal, in females, caused by non-penicillinase-producing strains of N. gonorrhoeae, and early Lyme disease (erythema migrans) caused by Borrelia burgdorferi.
Injection: Alternative drug for infections due to susceptible organisms eg, otitis media, orbital cellulitis, urinary tract, skin and soft tissue, bone and joint infections and post-sphenectomy sepsis of unclear etiology.